Search Results - "OSTER, Laurence"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Risk management strategies in the postmarketing period : Safety experience with the US and european bosentan surveillance programmes by SEGAL, Eleanor S, VALETTE, Cecile, OSTER, Laurence, BOULEY, Luc, EDFJALL, Catarina, HERRMANN, Peter, RAINERI, Massimo, KEMPFF, Mary, BEACHAM, Saundra, VAN LIEROP, Cinda

    Published in Drug safety (01-01-2005)
    “…In view of the shortcomings of the current system for postmarketing drug surveillance that is based on voluntary spontaneous adverse drug reaction (ADR)…”
    Get full text
    Journal Article
  2. 2

    Effects of Renin-Angiotensin Blockade on Sympathetic Reactivity and beta-Adrenergic Pathway in the Spontaneously Hypertensive Rat by Laflamme, Annik K, Oster, Laurence, Cardinal, Rene, de Champlain, Jacques

    Published in Hypertension (Dallas, Tex. 1979) (01-08-1997)
    “…As interactions between the renin-angiotensin and sympathetic nervous systems have been suggested in the pathogenesis of hypertension, we wanted to investigate…”
    Get full text
    Journal Article
  3. 3

    Effects of chronic treatment with losartan and enalaprilat on [ 3H]-Norepinephrine release from isolated atria of wistar-kyoto and spontaneously hypertensive rats by Foucart, Sylvain, Patrick, Susan K., Oster, Laurence, de Champlain, Jacques

    Published in American journal of hypertension (1996)
    “…The present study was designed to evaluate the effect of chronic treatment with losartan, an AT 1 angiotensin II receptor antagonist, and enalaprilat, an…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension by K-Laflamme, A, Oster, L, Cardinal, R, de Champlain, J

    “…This study was designed to investigate the effects of chronic inhibition of NO synthesis as well as chronic angiotensin receptor blockade with losartan in the…”
    Get more information
    Journal Article
  6. 6

    Altered Protein Kinase C Regulation of Phosphoinositide-Coupled Receptors in Deoxycorticosterone Acetate-Salt Hypertensive Rats by Calderone, Angelino, Oster, Laurence, Moreau, Pierre, Rouleau, Jean-Lucien, Stewart, Duncan J, de Champlain, Jacques

    Published in Hypertension (Dallas, Tex. 1979) (01-06-1994)
    “…This study examined the contribution of phosphatidylinositol metabolism and the efficacy of protein kinase C-mediated desensitization in the exaggerated…”
    Get full text
    Journal Article
  7. 7

    The vasorelaxant effect of deuterium oxide is secondary to calcium-induced liberation of nitric oxide by endothelial cells by Wang, R, Oster, L, de Champlain, J, Sauvé, R

    Published in Journal of hypertension (01-10-1993)
    “…To test the hypothesis that deuterium oxide (D2O) might induce endothelium-dependent and nitric oxide-mediated vasodilation by altering intracellular calcium…”
    Get more information
    Journal Article
  8. 8

    Norepinephrine and serotonin increase the vasoconstrictor response of the perfused rat tail artery to changes in cytosolic Ca2 by Thorin-Trescases, N, Oster, L, Atkinson, J, Capdeville, C

    Published in European journal of pharmacology (25-04-1990)
    “…Vasoconstriction and changes in cytosolic free Ca2+ concentrations (fura 2 with dual wavelength excitation) were measured simultaneously in the perfused tail…”
    Get more information
    Journal Article
  9. 9
  10. 10

    In vitro vasoconstriction induced by calcium in renovascular hypertensive or old rats by Oster, L, Chillon, J M, Henrion, D, Capdeville, C, Burlet, C, Atkinson, J

    Published in Life sciences (1973) (1990)
    “…We studied the changes in calcium-induced vasoconstriction in isolated tail arteries from young (2 months) and old (12 months) normotensive, and young…”
    Get more information
    Journal Article